Noxopharm (NOX) Short Interest

Noxopharm (ASX:NOX) had 0.00% of shares reported as short positions as of 24 Aug 2026, representing 4,188 shares. Noxopharm operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Noxopharm logo
NOX

Noxopharm

Pharmaceuticals, Biotechnology & Life Sciences

Noxopharm Limited is an Australian clinical-stage drug development company focused on creating innovative treatments for cancer and cytokine release syndrome (septic shock). The company is dedicated to improving patient outcomes through novel therapies and has a pipeline of drug candidates targeting unmet medical needs in oncology and inflammation.

Short position

short percentage0.00%
reported shorts4.2K
shares on issue307.238M

Noxopharm (ASX:NOX) has 0.00% of its shares on issue reported as short positions as of 24 Aug 2026, or about 4,188 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 2.78% in September 2016. NOX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Weekly context: The 10 most shorted ASX stocks — Week 38, 2026.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

NOX intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required
Short interest history & FAQ

NOX Short Interest History

30-day change
+0.00pp
90-day change
+0.00pp
1-year change
+0.00pp
All-time high
2.78% (September 2016)
All-time low
0.00% (July 2025)

Is NOX heavily shorted?

Not especially: 0.00% short interest is modest by ASX standards, ranking #661 of 819 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.

How has NOX's short interest changed recently?

Over the past 30 days Noxopharm's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.

What is the highest NOX's short interest has been?

Since 2016, Noxopharm's short interest peaked at 2.78% in September 2016 and bottomed at 0.00% in July 2025.

Where does this data come from?

All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2016. See our methodology.

Company

AI-generated research profile of Noxopharm

pharmaceuticals
biotechnology
cancer treatment
drug development
cytokine release syndrome

About

address

Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000

More Pharmaceuticals, Biotechnology & Life Sciences Stocks

Other shorted stocks in this sector

Be the first to discuss NOX

Start a research thread or post the first pulse update